Metrics
6 Record Views
- Title
- A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG Z5041 trial (Alliance)
- Creators
- Alice Chia-chi Wei - University of Toronto, Toronto, ON, CanadaFang-Shu Ou - Mayo Clinic, Rochester, MNQian Shi - Mayo Clinic, Rochester, MNEileen Mary O'Reilly - Memorial Sloan Kettering Cancer Center, New York, NYJeffrey A Meyerhardt - Dana-Farber Cancer Institute/ Partners Cancer Care, Boston, MARobert A Wolff - Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TXHedy L Kindler - University of Chicago, Chicago, ILDouglas B Evans - Medical College of Wisconsin, Milwaukee, WIVikram Deshpande - Massachusetts General Hospital, Boston, MAJoseph Misdraji - Department of Pathology, Massachusetts General Hospital, Boston, MAEric P Tamm - University of Texas MD Anderson Cancer Center, Houston, TXDushyant Sahani - Massachusetts General Hospital, Boston, MAMalcolm J Moore - BC Cancer Agency, Vancouver, BC, CanadaElliot Newman - New York University Cancer Institute, New York, NYNipun B Merchant - Vanderbilt University Ingram Cancer Center, Nashville, TNJordan Berlin - Vanderbilt University Ingram Cancer Center, Nashville, TNLaura Williams Goff - Vanderbilt University Medical Center, Nashville, TNPeter W. T Pisters - The University of Texas MD Anderson Cancer Center, Houston, TXMitchell C Posner - The University of Chicago Medicine, Chicago, ILACOSOG (Alliance)
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.4112-4112
- Academic Unit
- Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Surgical Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031597947602976